| Literature DB >> 27343012 |
Hyoung Kyu Kim1,2, Tae Hee Ko1, Bayalagmaa Nyamaa1, Sung Ryul Lee1,2, Nari Kim1, Kyung Soo Ko1, Byoung Doo Rhee1, Chul-Seung Park3, Bernd Nilius4, Jin Han5.
Abstract
Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to autosomal recessive non-syndromic mental retardation. Several key findings suggest diverse roles of CRBN, including its regulation of the large-conductance calcium- and voltage-activated potassium (BKCa) channels, regulation of thalidomide-binding proteins, and mediation of lenalidomide treatment in multiple myeloma. Recent studies also indicate that CRBN is involved in energy metabolism and negatively regulates AMP-activated protein kinase signaling. Mice with genetic depletion of CRBN are resistant to various stress conditions including a high-fat diet, endoplasmic reticulum stress, ischemia/reperfusion injury, and alcohol-related liver damage. In this review, we discuss the various roles of CRBN in human health and disease and suggest avenues for further research to enhance our basic knowledge and clinical application of CRBN.Entities:
Keywords: AMPK; BKCa; Cereblon; E3 ligase complex; Immunomodulatory drugs; Mental retardation
Mesh:
Substances:
Year: 2016 PMID: 27343012 DOI: 10.1007/s00424-016-1854-1
Source DB: PubMed Journal: Pflugers Arch ISSN: 0031-6768 Impact factor: 3.657